Continued Progress on Exenatide
New Drug Application planned for submission in mid-2004
Phase 3 data being submitted to medical journals and meetings
Further the scientific understanding of exenatide
- Additional studies planned and ongoing
- Comparator studies, combination studies, monotherapy
- NIH study examining exenatide’s effect on residual beta-cell function in people with type 1 diabetes